Edited by
Rory Pheiffer 
New Tools for Arguing Against the Use of Hindsight and Common Sense in Obviousness Rejections
In a victory for patent applicants and owners, a recent decision by the Federal Circuit re-emphasized the importance of the Graham factors to avoid the ever-present risk of using hindsight when making an obviousness determination, and questioned the all-too-familiar reliance on "common sense" to make obviousness arguments. In Mintz v. Dietz & Watson, Inc., the court vacated a previous summary judgment ruling of obviousness against the patentee of a patent directed to a casing structure for encasing meat products. In the decision, the court repeatedly warned against "the forbidden use of hindsight" and the "prohibited reliance on hindsight," as well as the need for "a court to walk a tightrope blindfolded (to avoid hindsight)." Patent applicants and plaintiffs will likely find the court's warnings useful in support of arguments against obviousness.
For a further discussion of Mintz, and practical tips about addressing obviousness rejections in view of the same, click here.
PTO Launches New IDS Program for Citing References After Issue Fee Has Been Paid
The United States Patent and Trademark Office (PTO) recently launched a new Information Disclosure Statement (IDS) pilot program aimed to assist applicants in citing references after prosecution has essentially been completed. This "Quick Path IDS" pilot program will, in many cases, allow applicants to have an IDS considered after payment of the issue fee without the expense and delay associated with filing a Request for Continued Examination (RCE).
To read more about how applicants can utilized the Quick Path IDS pilot program to their advantage, click here.
PTO Issues New Guidelines for Evaluating Certain Types of
Process Claims in view of Mayo v. Prometheus
On July 5, 2012, the PTO issued much-anticipated guidance for examining the patent eligibility of process claims that encompass laws of nature in light of the Supreme Court decision Mayo v. Prometheus. While these guidelines will undoubtedly impact biotechnology claims, they will also be applicable to any process claim that refers to a natural principle. In order to be patent-eligible, any such claim should include elements that integrate the natural principle into the claimed invention such that the principle is practically applied and the claim amounts to significantly more than the principle itself. These guidelines are considered to be a "stop-gap" measure while the PTO awaits the Federal Circuit's resolution of relevant pending cases that will further interpret Mayo, which will in turn lead to refined guidance. For now, patent applicants and patent owners with affected inventions and/or applications should carefully consider the recent guidelines, monitor ongoing developments in the courts, and consult their patent counsel to determine whether corrective action is necessary.
To read more about the PTO's guidance on process claims that encompass natural principles as detailed in a Nutter client alert distributed on July 6, 2012, click here.
Federal Circuit Responds to Prometheus by Finding It Must Be "Manifestly Evident" that Claim Is Directed to an Abstract Idea to Be Invalid for that Reason Under 35 U.S.C. § 101
In the wake of the Supreme Court's recent decision in Prometheus v. Mayo, the Federal Circuit held in CLS Bank v. Alice Corp. in a 2-1 decision that it must be "manifestly evident" that a claim is directed to an abstract idea for the claim to be invalid for that reason under 35 U.S.C. § 101. The court held that the single most reasonable conclusion must be that the "claim is directed to nothing more than a fundamental truth or disembodied concept, with no limitations in the claim attaching that idea to a specific application" for the claim to be invalid for claiming an abstract idea. The majority also noted that sections 102, 103, and 112 of 35 U.S.C. are equally as important as § 101, and that a district court is free to address invalidity issues in whatever order it chooses. It is anticipated that CLS Bank will cause courts to more zealously toss § 101 issues aside to find patents invalid under §§ 102 and 103 instead. However, in instances in which § 101 issues are addressed, it appears the bar has been raised if a defendant wants to argue a claim is invalid for being directed to an abstract idea. With that said, given the very divergent opinions between the majority and dissent, there is a reasonable prospect that CLS Bank will eventually be heard en banc or by the Supreme Court.
For a further discussion of CLS Bank, and possible implications of the decision, click here.
Objective Recklessness Prong of Willful Patent Infringement Test Is a Question of Law
About five years ago, the Federal Circuit in In re Seagate Technology set-out a two-prong
test for proving a patent was willfully infringed: (1) patentee
must show by clear-and-convincing evidence that the infringer acted
despite an objectively high likelihood that its actions constituted
infringement of a valid patent; and (2) patentee must also
demonstrate that this objectively-defined risk was either known or
so obvious that it should have been known to the accused
infringer. In a recent decision Bard Peripheral v. W.L.
Gore, the Federal Circuit provided further insight to this
test by holding that the first prong, i.e., whether a
defendant's actions were objectively reckless, is a question of
law to be determined by the judge. While the second prong and
the ultimate determination of willful infringement remains a
question for the jury to decide, it is anticipated that when a
judge finds a defendant acted in an objectively reckless manner, a
jury will find in favor of the second prong, and thus in favor of
willful infringement. However, by putting the first question
in the hands of the judge, it is also anticipated that there will
be fewer findings of objective recklessness because many consider
it more difficult to convince a judge than a jury that a
defendant's actions were objectively reckless. Of note to
litigators is that the objective reckless determination is now
subject to de novo review, i.e., without
deference to the lower court's decision, because the
determination is a question of law.
To read the Federal Circuit's decision in Bard Peripheral
v. W.L. Gore, click here.
New Trademark Search Tool from WIPO Allows for
Easy International Trademark Searching
The World Intellectual Property Organization (WIPO) recently
introduced the Global Brand Database, a new search tool for
internationally protected trademarks, appellations of origin and
armorial bearings, flags and other state emblems, and the names,
abbreviations and emblems of intergovernmental organizations.
The tool allows free of charge, simultaneous brand-related searches
across multiple collections.
For more information about the Global Brand Database and ways it
can help trademark applicants and owners,
click here.
Federal Circuit "Reverses" Itself, Illustrating Benefits of Pairing Reexamination with Patent Infringement Law Suits
The Federal Circuit's recent decision in In re Baxter International confirmed that
reexamination proceedings at the PTO may properly result in a
different patentability determination than declaratory judgment
proceedings in Federal Court for the same patent and the same
evidence. In Baxter, the Court affirmed a
reexamination decision by the PTO declaring certain claims of a
patent to be invalid for obviousness, even though the Court had
previously upheld the same claims' validity on appeal from an
action for declaratory judgment in the District Court. Thus,
the Court demonstrated that it is willing to rely on a
patentability determination by the PTO that conflicts with its own
determination, providing even greater incentives to file for
reexamination instead of or in addition to challenging a patent in
court.
For a further discussion of the In re Baxter decision,
and some incentives associated with filing a reexamination request
in lieu of or in addition to filing an infringement law suit,
click here.
PTO Satellite Offices Coming to Denver, Dallas, and San Jose
On July 2, 2012, the PTO announced plans to open regional PTO
offices in Denver, Colorado, Dallas, Texas, and San Jose,
California. These three offices, along with the regional office
that just opened this past week in Detroit, Michigan, will be used
to work with entrepreneurs to process patent applications, reduce
the backlog of unexamined patents and appeals of examiner
rejections, and speed up the overall patent application process.
The PTO plans to establish a timeline for opening the newly
announced offices in the coming months. The PTO is also currently
working on establishing a model for how the regional offices will
be set-up and operate in conjunction with the main office in
Alexandria, Virginia. This model will likely evolve based on
lessons learned from the new Detroit office. We note that the
Boston Patent Law Association (BPLA) spearheaded an effort to bring
one of the regional offices to the New England region. While we are
disappointed that the exceptional bid prepared by the BPLA was
unsuccessful, the new offices will certainly help our clients even
if they do not have offices in Detroit, Denver, Dallas, or San Jose
as these regional offices continue to support the PTO's efforts
to expedite patent prosecution. Stay tuned to future updates from
Nutter about the set-up and operation of the regional
offices.
For more information about the plans for the PTO satellite
offices, click here.
Nutter's IP Bulletin is a bi-monthly publication of the Intellectual Property Practice at Nutter McClennen & Fish LLP in Boston. This edition of the bulletin was edited by Rory P. Pheiffer. Assistance in the preparation of this issue was provided by Padma Choudry, Megan E. Jeans, Kevin C. McGrath, Kelly J. Morgan, Christopher J. Stow, and Michael P. Visconti.
This update is for information purposes only and should not be construed as legal advice on any specific facts or circumstances. Under the rules of the Supreme Judicial Court of Massachusetts, this material may be considered as advertising.
Discussing The Supreme Court's Oral Arguments In Myriad Gene Patenting Case (Video Content)
